May 01, 2021
2 min watch
Save
VIDEO: Presenter reviews retinal vascular disease treatment pipeline
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Jessica Steen, OD, FAAO, provides highlights from her SECO presentation that focused on the evolving trends in retinal vascular disease and the optometrist’s role in managing its treatment.
“Some of the treatment targets currently being investigated, for example in macular degeneration, are looking at features of the complement system and complement overactivation as an underlying feature of a driver of the macular degeneration spectrum,” Steen said.
Published by:
Sources/Disclosures
Collapse
Source:
Steen J. Evolving trends in retinal vascular disease. Presented at: SECO; Atlanta, Georgia; April 28-May 2, 2021.
Disclosures:
Steen reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.